Open Access. Powered by Scholars. Published by Universities.®
- Discipline
-
- Diseases (11)
- Cardiovascular Diseases (10)
- Medical Sciences (3)
- Pediatrics (3)
- Surgery (3)
-
- Endocrine System Diseases (2)
- Endocrinology, Diabetes, and Metabolism (2)
- Medical Pharmacology (2)
- Nutritional and Metabolic Diseases (2)
- Analytical, Diagnostic and Therapeutic Techniques and Equipment (1)
- Biochemistry, Biophysics, and Structural Biology (1)
- Chemicals and Drugs (1)
- Circulatory and Respiratory Physiology (1)
- Congenital, Hereditary, and Neonatal Diseases and Abnormalities (1)
- Family Medicine (1)
- Life Sciences (1)
- Nephrology (1)
- Oncology (1)
- Other Analytical, Diagnostic and Therapeutic Techniques and Equipment (1)
- Therapeutics (1)
- Keyword
-
- Hypertension (10)
- Left (4)
- Cardiac Surgical Procedures (3)
- Cardiovascular Diseases (3)
- Ventricular Dysfunction (3)
-
- Antihypertensive Agents (2)
- Cardiomyopathies (2)
- Chronic (2)
- Drug Therapy (2)
- Echocardiography (2)
- Heart Failure (2)
- Heart Ventricles (2)
- Infant (2)
- Postoperative Hemorrhage (2)
- 1-vessel obstructive coronary artery disease (1-vessel obstructive CAD); Electrocardiogram (ECG); ST-elevation myocardial infarction (STEMI); coronary angiography; non-ST-elevation myocardial infarction (NSTEMI) (1)
- Aged (1)
- Amyloidosis; Autopsy; Coronary Disease; Renal Dialysis (1)
- Aortitis; aortic aneurysm; idiopathic aortitis (IDA) (1)
- Apical ballooning syndrome; Takotsubo cardiomyopathy; selective serotonin-norepinephrine reuptake inhibitors; stress-induced cardiomyopathy (1)
- Arterial Pressure (1)
- Atherosclerosis; fibromuscular dysplasia; renal artery stenosis (1)
- Atrial Fibrillation (1)
- Beta-blockers (1)
- Blood Banks (1)
- Blood Pressure Monitoring (1)
- Blood Transfusion (1)
- Blood pressure; flavonoids; high blood pressure; hypertension; lipids; meta‐analysis; nutrition; quercetin (1)
- Brain Damage (1)
- Cardiac output; syncope; tilt‐table testing; vasoconstriction; vasovagal syncope; child (1)
- Cardiopulmonary Bypass (1)
Articles 31 - 34 of 34
Full-Text Articles in Cardiology
Effects Of Quercetin On Blood Pressure: A Systematic Review And Meta-Analysis Of Randomized Controlled Trials, Maria-Corina Serban, Alberto Zanchetti, George Howard, Diana Antal, Wilbert S. Aronow, Lipid And Blood Pressure Meta-Analysis Collaboration (Lbpmc) Group
Effects Of Quercetin On Blood Pressure: A Systematic Review And Meta-Analysis Of Randomized Controlled Trials, Maria-Corina Serban, Alberto Zanchetti, George Howard, Diana Antal, Wilbert S. Aronow, Lipid And Blood Pressure Meta-Analysis Collaboration (Lbpmc) Group
NYMC Faculty Publications
BACKGROUND: Quercetin, the most abundant dietary flavonol, has antioxidant effects in cardiovascular disease, but the evidence regarding its effects on blood pressure (BP) has not been conclusive. We assessed the impact of quercetin on BP through a systematic review and meta-analysis of available randomized controlled trials.
METHODS AND RESULTS: We searched PUBMED, Cochrane Library, Scopus, and EMBASE up to January 31, 2015 to identify placebo-controlled randomized controlled trials investigating the effect of quercetin on BP. Meta-analysis was performed using either a fixed-effects or random-effect model according to I(2) statistic. Effect size was expressed as weighted mean difference (WMD) and 95% …
Coronary-Artery Bypass Surgery In Patients With Ischemic Cardiomyopathy, Eric J. Velazquez, Julio A. Panza, Torsten Doenst, Patrice Desvigne-Nickens, George Sopko, Stiches Investigators
Coronary-Artery Bypass Surgery In Patients With Ischemic Cardiomyopathy, Eric J. Velazquez, Julio A. Panza, Torsten Doenst, Patrice Desvigne-Nickens, George Sopko, Stiches Investigators
NYMC Faculty Publications
BACKGROUND: The survival benefit of a strategy of coronary-artery bypass grafting (CABG) added to guideline-directed medical therapy, as compared with medical therapy alone, in patients with coronary artery disease, heart failure, and severe left ventricular systolic dysfunction remains unclear.
METHODS: From July 2002 to May 2007, a total of 1212 patients with an ejection fraction of 35% or less and coronary artery disease amenable to CABG were randomly assigned to undergo CABG plus medical therapy (CABG group, 610 patients) or medical therapy alone (medical-therapy group, 602 patients). The primary outcome was death from any cause. Major secondary outcomes included death …
Higher Risk For Incident Heart Failure And Cardiovascular Mortality Among Community-Dwelling Octogenarians Without Pneumococcal Vaccination, Momanna Ahmed, Kanan Patel, Gregg C. Fonarow, Charity J. Morgan, Javed Butler, Vera Bittner, Andrzej Kulczycki, Raya Kheirbek, Wilbert S. Aronow, Ross D. Fletcher, Cynthia J. Brown, Ali Ahmed
Higher Risk For Incident Heart Failure And Cardiovascular Mortality Among Community-Dwelling Octogenarians Without Pneumococcal Vaccination, Momanna Ahmed, Kanan Patel, Gregg C. Fonarow, Charity J. Morgan, Javed Butler, Vera Bittner, Andrzej Kulczycki, Raya Kheirbek, Wilbert S. Aronow, Ross D. Fletcher, Cynthia J. Brown, Ali Ahmed
NYMC Faculty Publications
AIMS: Octogenarians have the highest incidence of heart failure (HF) that is not fully explained by traditional risk factors. We explored whether lack of pneumococcal vaccination is associated with higher risk of incident HF among octogenarians.
METHODS AND RESULTS: In the Cardiovascular Health Study (CHS), 5290 community-dwelling adults, ≥65 years of age, were free of baseline HF and had data on pneumococcal vaccination. Of these, 851 were octogenarians, of whom, 593 did not receive pneumococcal vaccination. Multivariable-adjusted hazard ratios (aHR) and 95% confidence intervals (CI) for associations of lack of pneumococcal vaccination with incident HF and other outcomes during 13 …
Renal Artery Stenosis In A Young Female Without Fibromuscular Dysplasia With Literature Review, Paloma Peralta, Matthew Cholankeril, Daniel Goldberg, Jayanth Koneru, Fayez Shamoon
Renal Artery Stenosis In A Young Female Without Fibromuscular Dysplasia With Literature Review, Paloma Peralta, Matthew Cholankeril, Daniel Goldberg, Jayanth Koneru, Fayez Shamoon
NYMC Faculty Publications
Renal artery stenosis (RAS) is rare in young patients without fibromuscular dysplasia (FMD). RAS is primarily classified as having two major etiologies, namely, atherosclerosis and FMD, with 90% and 10%, respectively. We report a case of a female in her mid 20s who developed hypertension due to RAS with no evidence of FMD or underlying renal dysfunction and underwent successful angioplasty and stenting.